Sacubitril/Valsartan Improves Left Atrial and Left Atrial Appendage Function in Patients With Atrial Fibrillation and in Pressure Overload-Induced Mice
LCZ696 (sacubitril/valsartan) is an angiotensin receptor-neprilysin inhibitor and has shown beneficial effects in patients with heart failure. However, whether LCZ696 protects against left atrial (LA) and LA appendage (LAA) dysfunction is still unclear. The present study aimed to assess the efficacy...
Saved in:
Main Authors: | Ya Suo (Author), Meng Yuan (Author), Hongmin Li (Author), Yue Zhang (Author), Ying Li (Author), Huaying Fu (Author), Fei Han (Author), Changhui Ma (Author), Yuanyuan Wang (Author), Qiankun Bao (Author), Guangping Li (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Twice-daily rivaroxaban after percutaneous left atrial appendage closure for atrial fibrillation
by: Yang-Qi Pan, et al.
Published: (2024) -
Left atrial appendage function evaluated by transesophageal echocardiography in patients with atrial fibrillation.
by: Raymid García Fernández, et al.
Published: (2011) -
Left Ventricular Ejection Fraction Is Associated with the Risk of Thrombus in the Left Atrial Appendage in Patients with Atrial Fibrillation
by: Beata Uziębło-Życzkowska, et al.
Published: (2020) -
Predictors of Thrombus Dissolution in the Left Atrial Appendage in Patients with Persistent Nonvalvular Atrial Fibrillation
by: E. S. Mazur, et al.
Published: (2022) -
New prospects for assessing the hemostasis system in atrial fibrillation and left atrial appendage thrombosis
by: Z. A. Gebekova, et al.
Published: (2023)